Abide Tx: Serine hydrolase-targeted therapeutics harnessing the endocannabinoid system to address neurological and pain disorders w. limited or no treatment options. Ph 2: Tourette Syndrome ongoing with data expected in 1Q20; Ph 1b: neuropathic pain complete, with plans to initiate Ph 2 in 1H19.
Sector/industry:
Biotech Company
Characteristics:
Based in...
USA
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Central Nervous System
Listing
Private
Market Cap
Private
Website:
Address:
10835 Road to the Cure, Suite 250
San Diego, CA 92121
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.